Cargando…

Diagnostic markers for community-acquired pneumonia

Community-acquired pneumonia (CAP) is one of the respiratory infectious diseases caused by not only bacteria, but also viruses. Antibiotic agents are needed to treat only bacterial but not viral CAP. In addition, there are some non-infectious respiratory diseases in the differential diagnosis of CAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Akihiro, Ishida, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article on Advances in Laboratory Tests for Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290537/ https://www.ncbi.nlm.nih.gov/pubmed/32566635 http://dx.doi.org/10.21037/atm.2020.02.182

Ejemplares similares

The diagnostic utility of pleural markers for tuberculosis pleural effusion
por: Zhang, Man, et al.
Publicado: (2020)

Disease burden and molecular epidemiology of carbapenem-resistant Klebsiella pneumonia infection in a tertiary hospital in China
por: Kang, Haiquan, et al.
Publicado: (2020)

Laboratory diagnosis of infectious diseases: a call for more rapid and accurate methods
por: Hu, Zhi-De, et al.
Publicado: (2020)

Aetiology of community-acquired pneumonia in children treated in hospital
por: Korppi, M., et al.
Publicado: (1993)

Viruses and bacteria in sputum samples of children with community‐acquired pneumonia
por: Honkinen, M., et al.
Publicado: (2012)

Community-acquired Pneumonia Secondary to Legionella pneumophila and Streptococcus pneumoniae: A Rare Co-infection
por: Beg, Moeezullah, et al.
Publicado: (2019)

Transthoracic fine‐needle aspiration in the aetiological diagnosis of community‐acquired pneumonia
por: Hernes, S. S., et al.
Publicado: (2009)

A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine
por: Azzini, Anna Maria, et al.
Publicado: (2020)

Advances in laboratory assays for detecting human metapneumovirus
por: Jeong, Seri, et al.
Publicado: (2020)

Community-Acquired, Post-COVID-19, Methicillin-Resistant Staphylococcus aureus Pneumonia and Empyema
por: McCraw, Cameron, et al.
Publicado: (2022)

Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: a multicentre, prospective study
por: Lokida, Dewi, et al.
Publicado: (2022)

Nosocomial cross-infection of hypervirulent Listeria monocytogenes sequence type 87 in China
por: Li, Xin-Peng, et al.
Publicado: (2020)

High clinical impact of rapid susceptibility testing on CHROMID ESBL(®) medium directly from swabs
por: Romo-Ibáñez, Álvaro, et al.
Publicado: (2020)

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with UF-5000i urine flow cytometry to directly identify pathogens in clinical urine specimens within 1 hour
por: Sun, Chuang, et al.
Publicado: (2020)

A hook-effect-free homogeneous light-initiated chemiluminescence assay: is it reliable for screening and the quantification of the hepatitis B surface antigen?
por: Yang, Ruifeng, et al.
Publicado: (2020)

Net benefit of routine urine parameters for urinary tract infection screening: a decision curve analysis
por: Han, Yan-Qiu, et al.
Publicado: (2020)

Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis
por: Gammon, Richard R., et al.
Publicado: (2021)

Community Acquired Pneumonia
por: Finch, Roger
Publicado: (1998)

The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
por: Viasus, Diego, et al.
Publicado: (2015)

Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey
por: Chen, Liang, et al.
Publicado: (2018)

Correlation Between Serum Levels of 25-Hydroxyvitamin D and Severity of Community-Acquired Pneumonia in Hospitalized Patients Assessed by Pneumonia Severity Index: An Observational Descriptive Study
por: Georgakopoulou, Vasiliki E, et al.
Publicado: (2020)

Community-acquired pneumonia in hospitalised patients: changes in aetiology, clinical presentation, and severity outcomes in a 10-year period
por: Sellarès-Nadal, Júlia, et al.
Publicado: (2022)

Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis
por: Furukawa, Yuki, et al.
Publicado: (2023)

Evaluation of a Rapid Urine Antigen Detection Assay as a Point-of-Care Test in the Diagnosis of Community-Acquired Pneumonia
por: Khaleel, Mohammed, et al.
Publicado: (2023)

Prevalence of Hospital-Acquired Pneumonia Among Patients With Severe to Critical COVID-19 Pneumonia Given Tocilizumab
por: Adre, Lorenzo Abednego B, et al.
Publicado: (2023)

Incidence rate of community-acquired pneumonia in adults: a population-based prospective active surveillance study in three cities in South America
por: Lopardo, Gustavo Daniel, et al.
Publicado: (2018)

Aeromonas hydrophila Community-Acquired Bacterial Pneumonia With Septic Shock in a Chronic Lymphocytic Leukemia Patient Due to Absolute Neutropenia and Lymphopenia
por: Patil, Sachin M, et al.
Publicado: (2022)

Shorter versus longer durations of antibiotic treatment for patients with community-acquired pneumonia: a protocol for a systematic review and meta-analysis
por: Agarwal, Arnav, et al.
Publicado: (2022)

Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial
por: Israelsen, Simone Bastrup, et al.
Publicado: (2023)

A Case of Community-Acquired Elizabethkingia meningoseptica
por: Lee, Jae Woo, et al.
Publicado: (2023)

Legionella community-acquired pneumonia (CAP) presenting with spontaneous bilateral pneumothoraces
por: Cunha, Burke A., et al.
Publicado: (2008)

COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms
por: Nagappan, Radhika, et al.
Publicado: (2021)

Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil
por: Duarte, Fernanda Gross, et al.
Publicado: (2022)

Methicillin‐resistant Staphylococcus aureus and Pseudomonas aeruginosa community acquired pneumonia: Prevalence and locally derived risk factors in a single hospital system
por: Frazee, Bradley W., et al.
Publicado: (2023)

Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens
por: Santos, Emily F., et al.
Publicado: (2021)

Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

Association of hypercapnia on admission with increased length of hospital stay and severity in patients admitted with community-acquired pneumonia: a prospective observational study from Pakistan
por: Iqbal, Nousheen, et al.
Publicado: (2017)

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Meteorological factors and risk of community-acquired Legionnaires’ disease in Switzerland: an epidemiological study
por: Conza, Lisa, et al.
Publicado: (2013)

Long-term mortality after community-acquired sepsis: a longitudinal population-based cohort study
por: Wang, Henry E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jj6o39t2sg8v3ou1kgsnbknogq